Line 59: | Line 59: | ||
<ul> | <ul> | ||
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Model">Overview</a></li> | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Model">Overview</a></li> | ||
− | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Optimum_Aptamer_Concentration | + | <li style="font-size:8px !important;"><a href="https://2021.igem.org/Team:GreatBay_SCIE/Optimum_Aptamer_Concentration" >Optimum Liposome-Aptamer Ratio</a></li> |
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Drug_Loading">Drug Loading</a></li> | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Drug_Loading">Drug Loading</a></li> | ||
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/3D_Model">3D Models</a></li> | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/3D_Model">3D Models</a></li> |
Revision as of 09:28, 18 October 2021
![logo](https://static.igem.org/mediawiki/2021/6/6a/T--GreatBay_SCIE--Project_Logo.png)
![logo](https://static.igem.org/mediawiki/2021/0/06/T--GreatBay_SCIE--Team_Logo.png)